Q40824215 | A protein and mRNA expression-based classification of gastric cancer |
Q35078072 | ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status |
Q92972185 | Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications |
Q37488484 | Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization |
Q34954681 | Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer |
Q92646254 | Clinicopathological features and prognostic value of mismatch repair protein deficiency in gastric cancer |
Q34101774 | Comparative features of colorectal and gastric cancers with microsatellite instability in Chinese patients |
Q37536970 | Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy. |
Q41144846 | Correlation between gastric carcinoma and ZAC gene-associated microsatellite instability and loss of heterozygosity |
Q53653777 | Correlation between microsatellite instability-high phenotype and occult lymph node metastasis in gastric carcinoma. |
Q33820887 | Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in Early Gastric Cancer (EGC). |
Q36105548 | Endoscopic and clinicopathologic characteristics of early gastric cancer with high microsatellite instability |
Q40908062 | Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. |
Q37200235 | Expression of Mismatch Repair Proteins in Early and Advanced Gastric Cancer in Poland. |
Q51284026 | Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach. |
Q26780318 | HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach |
Q34305463 | Helicobacter pylori and Molecular Markers as Prognostic Indicators for Gastric Cancer in Korea |
Q82339519 | Hereditary gastric cancer: the pathologist's point of view |
Q54342844 | High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer. |
Q38864582 | High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability |
Q92354829 | Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer |
Q38204955 | Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis. |
Q51561153 | MSI phenotype and MMR alterations in familial and sporadic gastric cancer. |
Q47593232 | Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer. |
Q36658403 | Microsatellite Instability of Gastric and Colorectal Cancers as a Predictor of Synchronous Gastric or Colorectal Neoplasms |
Q35753579 | Microsatellite instability and survival in gastric cancer: A systematic review and meta-analysis |
Q55264193 | Microsatellite instability in prostate cancer by PCR or next-generation sequencing. |
Q48667067 | Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery |
Q36660380 | Microsatellite instability status in gastric cancer: a reappraisal of its clinical significance and relationship with mucin phenotypes |
Q92510487 | Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response |
Q60958385 | Molecular and Computational Methods for the Detection of Microsatellite Instability in Cancer |
Q37687784 | Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm |
Q50963140 | Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer. |
Q98771218 | The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer |
Q33888982 | The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy |
Q28083904 | The molecular background of mucinous carcinoma beyond MUC2 |
Q36037141 | Usefulness of Immunohistochemistry for Microsatellite Instability Screening in Gastric Cancer |
Search more.